info:eu-repo/semantics/article
A multi-country study of prevalence and early childhood mortality among children with omphalocele
Fecha
2020-12Registro en:
Nembhard, Wendy N.; Bergman, Jorieke E. H.; Politis, Maria D.; Arteaga Vázquez, Jazmín; Bermejo Sánchez, Eva; et al.; A multi-country study of prevalence and early childhood mortality among children with omphalocele; John Wiley & Sons Inc; Birth Defects Research; 112; 20; 12-2020; 1787-1801
2472-1727
CONICET Digital
CONICET
Autor
Nembhard, Wendy N.
Bergman, Jorieke E. H.
Politis, Maria D.
Arteaga Vázquez, Jazmín
Bermejo Sánchez, Eva
Canfield, Mark A.
Cragan, Janet
Dastgiri, Saeed
de Walle, Hermien E K
Feldkamp, Marcia L
Nance, Amy
Gatt, Miriam
Groisman, Boris
Hurtado Villa, Paula
Kallén, Kärin
Landau, Danielle
Lelong, Nathalie
López Camelo, Jorge Santiago
Martinez, Laura
Morgan, Margery
Pierini, Anna
Rissmann, Anke
Sípek, Antonin
Szabova, Elena
Tagliabue, Giovanna
Wertelecki, Wladimir
Zarante, Ignacio
Bakker, Marian K.
Kancherla, Vijaya
Mastroiacovo, Pierpaolo
Resumen
Background: Omphalocele is the second most common abdominal birth defect and often occurs with other structural and genetic defects. The objective of this study was to determine omphalocele prevalence, time trends, and mortality during early childhood, by geographical region, and the presence of associated anomalies. Methods: We conducted a retrospective study with 23 birth defect surveillance systems in 18 countries who are members of the International Clearinghouse for Birth Defects Surveillance and Research that submitted data on cases ascertained from 2000 through 2012, approximately 16 million pregnancies were surveyed that resulted in live births, stillbirths, or elective terminations of pregnancy for fetal anomalies (ETOPFA) and cases with omphalocele were included. Overall prevalence and mortality rates for specific ages were calculated (day of birth, neonatal, infant, and early childhood). We used Kaplan–Meier estimates with 95% confidence intervals (CI) to calculate cumulative mortality and joinpoint regression for time trend analyses. Results: The prevalence of omphalocele was 2.6 per 10,000 births (95% CI: 2.5, 2.7) and showed no temporal change from 2000–2012 (average annual percent change = −0.19%, p =.52). The overall mortality rate was 32.1% (95% CI: 30.2, 34.0). Most deaths occurred during the neonatal period and among children with multiple anomalies or syndromic omphalocele. Prevalence and mortality varied by registry type (e.g., hospital- vs. population-based) and inclusion or exclusion of ETOPFA. Conclusions: The prevalence of omphalocele showed no temporal change from 2000–2012. Approximately one-third of children with omphalocele did not survive early childhood with most deaths occurring in the neonatal period.